DENTSPLY SIRONA Inc. - stock earnings

XRAY Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
May 1, 2024 BeforeMarket 958.5 million 969.6 million 982.7 million

XRAY Quarterly earnings

DateEarningsRevenue
2023Q4 67.0 million USD 16.0 million USD
2023Q3 -266.0 million USD 947.0 million USD
2023Q2 86.0 million USD 1.0 billion USD
2023Q1 -23.0 million USD 978.0 million USD
2022Q4 -15.0 million USD 983.0 million USD
2022Q3 69.0 million USD 965.0 million USD
2022Q2 73.0 million USD 1.0 billion USD
2022Q1 65.0 million USD 965.0 million USD
2021Q4 102.0 million USD 1.1 billion USD
2021Q3 103.0 million USD 1.1 billion USD
2021Q2 99.0 million USD 1.1 billion USD
2021Q1 117.0 million USD 1.0 billion USD
2020Q4 99.0 million USD 1.1 billion USD
2020Q3 53.8 million USD 894.8 million USD
2020Q2 -95.4 million USD 490.6 million USD
2020Q1 -139.9 million USD 874.3 million USD
2019Q4 102.3 million USD 1.1 billion USD
2019Q3 85.0 million USD 962.1 million USD
2019Q2 36.4 million USD 1.0 billion USD
2019Q1 39.2 million USD 946.2 million USD
2018Q4 1.8 million USD 1.1 billion USD
2018Q3 28.0 million USD 928.4 million USD
2018Q2 -1.1 billion USD 1.0 billion USD
2018Q1 81.2 million USD 956.1 million USD
2017Q4 -673.4 million USD 1.1 billion USD
2017Q3 90.6 million USD 1.0 billion USD
2017Q2 -1.1 billion USD 992.7 million USD
2017Q1 59.8 million USD 900.5 million USD
2016Q4 107.0 million USD 996.5 million USD
2016Q3 92.5 million USD 954.2 million USD
2016Q2 105.4 million USD 1.0 billion USD
2016Q1 125.0 million USD 772.6 million USD
2015Q4 58.6 million USD 671.1 million USD
2015Q3 84.5 million USD 648.9 million USD
2015Q2 44.1 million USD 698.0 million USD
2015Q1 64.0 million USD 656.3 million USD
2014Q4 84.7 million USD 719.0 million USD
2014Q3 75.3 million USD 708.2 million USD
2014Q2 90.0 million USD 765.2 million USD
2014Q1 72.9 million USD 730.1 million USD
2013Q4 74.4 million USD 753.7 million USD
2013Q3 79.9 million USD 704.0 million USD
2013Q2 87.2 million USD 761.0 million USD
2013Q1 71.7 million USD 732.1 million USD
2012Q4 126.8 million USD 753.3 million USD
2012Q3 53.4 million USD 695.7 million USD
2012Q2 80.8 million USD 763.0 million USD
2012Q1 53.3 million USD 716.4 million USD
2011Q4 40.6 million USD 738.0 million USD
2011Q3 60.6 million USD 619.8 million USD
2011Q2 74.2 million USD 609.4 million USD
2011Q1 69.1 million USD 570.5 million USD
2010Q4 67.8 million USD 568.2 million USD
2010Q3 63.7 million USD 541.8 million USD
2010Q2 72.4 million USD 565.1 million USD
2010Q1 61.8 million USD 545.9 million USD
2009Q4 74.8 million USD 568.7 million USD
2009Q3 67.5 million USD 1.0 billion USD
2009Q2 70.2 million USD 1.1 billion USD
2009Q1 61.7 million USD 506.9 million USD
2008Q4 71.0 million USD 508.1 million USD
2008Q3 66.0 million USD 530.0 million USD
2008Q2 78.6 million USD 594.8 million USD
2008Q1 68.2 million USD 560.8 million USD
2007Q4 70.0 million USD 541.5 million USD
2007Q3 65.7 million USD 488.1 million USD
2007Q2 65.4 million USD 507.4 million USD
2007Q1 58.5 million USD 472.9 million USD
2006Q4 64.9 million USD 471.3 million USD
2006Q3 49.4 million USD 435.7 million USD
2006Q2 59.3 million USD 472.4 million USD
2006Q1 50.0 million USD 431.0 million USD
2005Q4 -724000 USD 447.4 million USD
2005Q3 -60.8 million USD 416.0 million USD
2005Q2 57.9 million USD 444.8 million USD
2005Q1 49.0 million USD 407.0 million USD
2004Q4 68.6 million USD 462.9 million USD
2004Q3 46.7 million USD 390.6 million USD
2004Q2 49.0 million USD 425.3 million USD
2004Q1 88.8 million USD 415.4 million USD
2003Q4 50.4 million USD 356.4 million USD
2003Q3 41.3 million USD 400.4 million USD
2003Q2 44.2 million USD 417.9 million USD
2003Q1 38.3 million USD 396.2 million USD
2002Q4 42.3 million USD 421.1 million USD
2002Q3 35.8 million USD 363.5 million USD
2002Q2 36.8 million USD 378.0 million USD
2002Q1 33.1 million USD 351.2 million USD
2001Q4 33.8 million USD 375.3 million USD
2001Q3 25.9 million USD 253.5 million USD
2001Q2 27.4 million USD 254.6 million USD
2001Q1 34.3 million USD 245.7 million USD
2000Q4 30.9 million USD 238.7 million USD
2000Q3 23.3 million USD 215.3 million USD
2000Q2 24.6 million USD 223.3 million USD
2000Q1 22.2 million USD 212.5 million USD
1999Q4 28.5 million USD 221.6 million USD
1999Q3 20.7 million USD 203.6 million USD
1999Q2 21.2 million USD 209.1 million USD
1999Q1 19.5 million USD 196.6 million USD
1998Q4 -2.4 million USD 220.3 million USD
1998Q3 17.6 million USD 197.0 million USD
1998Q2 600000 USD 197.1 million USD
1998Q1 19.0 million USD 180.7 million USD
1997Q4 23.6 million USD 197.5 million USD
1997Q3 16.3 million USD 172.7 million USD
1997Q2 17.8 million USD 178.3 million USD
1997Q1 16.9 million USD 172.4 million USD
1996Q4 20.6 million USD 180.3 million USD
1996Q3 13.9 million USD 155.3 million USD
1996Q2 17.8 million USD 165.0 million USD
1996Q1 18.3 million USD 161.7 million USD
1995Q4 18.3 million USD 161.7 million USD
1995Q3 9.5 million USD 137.3 million USD
1995Q2 13.2 million USD 139.9 million USD
1995Q1 13.0 million USD 133.1 million USD
1994Q4 21.8 million USD 140.1 million USD
1994Q3 13.9 million USD 129.9 million USD
1994Q2 14.0 million USD 141.1 million USD
1994Q1 12.4 million USD 140.4 million USD
1993Q4 -300000 USD 147.8 million USD
1993Q3 11.0 million USD 133.5 million USD
1993Q2 -4.2 million USD 131.8 million USD
1993Q1 4.8 million USD 44.5 million USD
1992Q4 4.3 million USD 44.1 million USD
1992Q3 3.5 million USD 38.7 million USD
1992Q2 2.1 million USD 28.9 million USD
1992Q1 1.7 million USD 23.5 million USD
1991Q4 1.5 million USD 21.4 million USD
1991Q3 1.2 million USD 20.5 million USD
1991Q2 900000 USD 19.2 million USD
1991Q1 700000 USD 18.5 million USD
1990Q4 700000 USD 17.6 million USD
1990Q3 700000 USD 10.7 million USD
1990Q2 700000 USD 7.8 million USD
1990Q1 600000 USD 7.9 million USD
1989Q4 600000 USD 7.0 million USD
1989Q3 600000 USD 7.3 million USD
1989Q2 500000 USD 7.3 million USD
1989Q1 ? USD 4.6 million USD
1988Q4 ? USD 4.9 million USD
1988Q3 ? USD 4.9 million USD
1988Q2 ? USD 4.1 million USD
1988Q1 ? USD 4.3 million USD
1987Q4 ? USD 4.4 million USD
1987Q3 ? USD 4.0 million USD
1987Q2 ? USD 3.6 million USD
1987Q1 ? USD 3.2 million USD
1986Q4 ? USD 3.2 million USD
1986Q3 ? USD 3.2 million USD
1986Q2 ? USD 3.1 million USD
1986Q1 ? USD 2.6 million USD
1985Q4 ? USD 2.6 million USD
1985Q3 ? USD 2.6 million USD

XRAY Yearly earnings

DateEarningsRevenue
2023 -132.0 million USD 4.0 billion USD
2022 -950.0 million USD 3.9 billion USD
2021 411.0 million USD 4.3 billion USD
2020 -83.0 million USD 3.3 billion USD
2019 262.9 million USD 4.0 billion USD
2018 -1.0 billion USD 4.0 billion USD
2017 -1.6 billion USD 4.0 billion USD
2016 429.9 million USD 3.7 billion USD
2015 251.2 million USD 2.7 billion USD
2014 322.9 million USD 2.9 billion USD
2013 313.2 million USD 3.0 billion USD
2012 314.2 million USD 2.9 billion USD
2011 244.5 million USD 2.5 billion USD
2010 265.7 million USD 2.2 billion USD
2009 274.3 million USD 2.2 billion USD
2008 283.9 million USD 2.2 billion USD
2007 259.7 million USD 2.0 billion USD
2006 223.7 million USD 1.8 billion USD
2005 45.4 million USD 1.7 billion USD
2004 253.2 million USD 1.7 billion USD
2003 174.2 million USD 1.6 billion USD
2002 148.0 million USD 1.5 billion USD
2001 121.5 million USD 1.1 billion USD
2000 101.0 million USD 889.8 million USD
1999 89.9 million USD 830.9 million USD
1998 34.8 million USD 795.1 million USD
1997 74.6 million USD 720.8 million USD
1996 67.2 million USD 656.6 million USD
1995 54.0 million USD 572.0 million USD
1994 62.0 million USD 524.8 million USD
1993 14.1 million USD 552.6 million USD
1992 14.6 million USD 156.2 million USD
1991 5.3 million USD 84.6 million USD
1990 2.9 million USD 54.5 million USD
1989 2.4 million USD 29.4 million USD
1988 1.7 million USD 18.6 million USD
1987 1.3 million USD 16.2 million USD
1986 800000 USD 12.7 million USD
1985 100000 USD 10.3 million USD

XRAY

List: Contenders

Price: $30.92

52 week price:
26.27
43.24

Dividend Yield: 0.02%

5-year range yield:
0.02%
1.92%

Forward Dividend Yield: 2.07%

Payout Ratio: -63.37%

Payout Ratio Range:
-184.67%
94.75%

Dividend Per Share: 0.64 USD

Earnings Per Share: -0.62 USD

P/E Ratio: -33

Exchange: NMS

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 2.6 million

Ebitda: 187.9 million

Market Capitalization: 6.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 31

DGR3: 10.05%

DGR5: 4.18%

DGR10: 9.33%

DGR20: 9.45%

Links: